We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAYS icon
3601
J.W. Mays
MAYS
$82.1M
$12.6K ﹤0.01%
287
-9
-3% -$391
BYRN icon
3602
Byrna Technologies
BYRN
$96.9M
$12.6K ﹤0.01%
438
-1,440
-77% -$28.2K
ONT
3603
Onterris Inc
ONT
$576M
$12.6K ﹤0.01%
680
-4,018
-86% -$84.5K
AVDL
3604
DELISTED
Avadel Pharmaceuticals
AVDL
$12.6K ﹤0.01%
1,199
-9,301
-89% -$113K
TSQ icon
3605
Townsquare Media
TSQ
$104M
$12.6K ﹤0.01%
1,386
+419
+43% +$4.2K
RMNI icon
3606
Rimini Street
RMNI
$445M
$12.6K ﹤0.01%
4,717
+961
+26% +$1.96K
FSTR icon
3607
Foster
FSTR
$405M
$12.6K ﹤0.01%
468
-2,703
-85% -$64.7K
ALB.PRA icon
3608
Albemarle Corp Depositary Shares
ALB.PRA
$2.51B
$12.6K ﹤0.01%
+309
New +$14.3K
PAYS icon
3609
Paysign
PAYS
$723M
$12.6K ﹤0.01%
4,161
+1,743
+72% +$6.11K
LCTX icon
3610
Lineage Cell Therapeutics
LCTX
$268M
$12.5K ﹤0.01%
24,930
+12,540
+101% +$9.21K
UNTY icon
3611
Unity Bancorp
UNTY
$619M
$12.5K ﹤0.01%
287
-16
-5% -$671
TIGO icon
3612
Millicom
TIGO
$16.2B
$12.5K ﹤0.01%
500
-2,090
-81% -$54.8K
LYEL icon
3613
Lyell Immunopharma
LYEL
$347M
$12.5K ﹤0.01%
975
+562
+136% +$11.1K
LFVN icon
3614
LifeVantage
LFVN
$82.1M
$12.5K ﹤0.01%
711
-198
-22% -$2.78K
RILY icon
3615
BRC Group Holdings
RILY
$304M
$12.5K ﹤0.01%
2,713
-4,187
-61% -$21.8K
SCPH
3616
DELISTED
scPharmaceuticals
SCPH
$12.4K ﹤0.01%
3,513
-474
-12% -$1.82K
MRNS
3617
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.4K ﹤0.01%
23,199
+9,434
+69% +$6.57K
SMOT icon
3618
VanEck Morningstar SMID Moat ETF
SMOT
$340M
$12.4K ﹤0.01%
+360
New +$12.9K
FRAF icon
3619
Franklin Financial Services
FRAF
$289M
$12.4K ﹤0.01%
415
+78
+23% +$2.49K
WF icon
3620
Woori Financial
WF
$17.1B
$12.4K ﹤0.01%
+396
New +$13.7K
MLYS icon
3621
Mineralys Therapeutics
MLYS
$2.39B
$12.4K ﹤0.01%
1,005
-1,669
-62% -$21.8K
DBD icon
3622
Diebold Nixdorf
DBD
$2.45B
$12.4K ﹤0.01%
287
+182
+173% +$8.2K
ONIT
3623
Onity Group
ONIT
$321M
$12.3K ﹤0.01%
402
-1,736
-81% -$53.7K
APPS icon
3624
Digital Turbine
APPS
$1.5B
$12.3K ﹤0.01%
7,302
-18,280
-71% -$40.7K
HWBK icon
3625
Hawthorn Bancshares
HWBK
$276M
$12.3K ﹤0.01%
435
+270
+164% +$7.57K

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.